Amarantus Bioscience Book Value Per Share vs. Current Asset
| AMBS Stock | USD 0.0001 0.00 0.00% |
For Amarantus Bioscience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Amarantus Bioscience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Amarantus Bioscience Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Amarantus Bioscience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Amarantus Bioscience Holdings over time as well as its relative position and ranking within its peers.
Amarantus |
Amarantus Bioscience Current Asset vs. Book Value Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Amarantus Bioscience's current stock value. Our valuation model uses many indicators to compare Amarantus Bioscience value to that of its competitors to determine the firm's financial worth. Amarantus Bioscience Holdings is number one stock in book value per share category among its peers. It also is number one stock in current asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amarantus Bioscience's earnings, one of the primary drivers of an investment's value.Amarantus Current Asset vs. Book Value Per Share
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Amarantus Bioscience |
| = | (0.12) X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Amarantus Bioscience |
| = | 942 K |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Amarantus Current Asset Comparison
Amarantus Bioscience is currently under evaluation in current asset category among its peers.
Amarantus Bioscience Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Amarantus Bioscience, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Amarantus Bioscience will eventually generate negative long term returns. The profitability progress is the general direction of Amarantus Bioscience's change in net profit over the period of time. It can combine multiple indicators of Amarantus Bioscience, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York. Amarantus Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Amarantus Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Amarantus Bioscience. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Amarantus Bioscience position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Amarantus Bioscience's important profitability drivers and their relationship over time.
Use Amarantus Bioscience in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amarantus Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amarantus Bioscience will appreciate offsetting losses from the drop in the long position's value.Amarantus Bioscience Pair Trading
Amarantus Bioscience Holdings Pair Trading Analysis
The ability to find closely correlated positions to Amarantus Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amarantus Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amarantus Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amarantus Bioscience Holdings to buy it.
The correlation of Amarantus Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amarantus Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amarantus Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amarantus Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Amarantus Bioscience position
In addition to having Amarantus Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Municipals ETFs Thematic Idea Now
Municipals ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Municipals ETFs theme has 111 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Municipals ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Amarantus Pink Sheet Analysis
When running Amarantus Bioscience's price analysis, check to measure Amarantus Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarantus Bioscience is operating at the current time. Most of Amarantus Bioscience's value examination focuses on studying past and present price action to predict the probability of Amarantus Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarantus Bioscience's price. Additionally, you may evaluate how the addition of Amarantus Bioscience to your portfolios can decrease your overall portfolio volatility.